Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.
暂无分享,去创建一个
V. Haufroid | N. Pallet | B. Royer | M. Etienne-Grimaldi | E. Gautier‐Veyret | F. Thomas | C. Narjoz | C. Tron | M. Maillard | M. Launay | A. Schmitt
[1] G. Defossez,et al. Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France. , 2019, European journal of cancer.
[2] F. Pinguet,et al. New advances in DPYD genotype and risk of severe toxicity under capecitabine , 2017, PloS one.
[3] H. McLeod,et al. Dose and time dependencies of 5‐fluorouracil pharmacokinetics , 2000, Clinical pharmacology and therapeutics.